The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day
NCT ID: NCT03344185
Last Updated: 2017-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2016-07-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low GI diet
This diet contained three meals, all with a low GI value. This was the Low Glycaemic Diet intervention.
Low Glycaemic Diet
This intervention consisted of three low GI meals.
High GI diet
This diet contained three meals, all with a high GI value. This was the High Glycaemic Diet intervention.
High Glycaemic Diet
This intervention consisted of three meals, all with a high GI value.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Glycaemic Diet
This intervention consisted of three low GI meals.
High Glycaemic Diet
This intervention consisted of three meals, all with a high GI value.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to participate in the entire study (signed informed consent required)
* Subjects will be eligible for the study if male or female (not pregnant or lactating)
Exclusion Criteria
* Smoker
* Have any food intolerances or allergies
* History of alcohol or drug misuse
* Diagnosed with any of the following:
* High blood cholesterol
* High blood pressure
* Thyroid disorder
* Heart problems, stroke or any vascular disease in the past 12 months
* Inflammatory diseases such as rheumatoid arthritis
* Bone related conditions, such as osteoporosis
* Renal, gastrointestinal, respiratory, liver disease or cancer
* You are presently taking part in another clinical trial or research study
* You are an elite athlete (very high intensity training more than 3 times a week)
* You are currently on a specific diet or taking any dietary supplements and are unwilling to cease during the testing period
* You are intending to regularly use medication which affects gastrointestinal motility
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Matthew Grout
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Grout
Doctoral Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel J Lamport, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Reading
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-032-DL
Identifier Type: -
Identifier Source: org_study_id